Relapsed Pediatric AML
6 clinical trials · Condition
◉ Watch Relapsed Pediatric AML
| Record | Firm | Date |
|---|---|---|
| TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia (NCT04033627) | Shanghai Children's Medical Center | 2020-11-10 |
| Vyxeos® With Clofarabine for Pediatric AML (NCT07156435) | Princess Maxima Center for Pediatric Oncology | 2020-11-06 |
| Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia (NCT04562792) | Children's Mercy Hospital Kansas City | 2020-05-08 |
| Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy (NCT02638428) | Samsung Medical Center | 2015-12-01 |
| Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation (NCT03245424) | Agios Pharmaceuticals, Inc. |
Track Relapsed Pediatric AML automatically
Every clearance here is in the API, with alerts when new ones post.